Squarepoint Ops LLC - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 133 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q3 2020. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.

Quarter-by-quarter ownership
Squarepoint Ops LLC ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q4 2020$363,000
+188.1%
290,532
+314.9%
0.00%
+50.0%
Q3 2020$126,000
-89.7%
70,026
-51.8%
0.00%
-90.0%
Q2 2020$1,218,000
+859.1%
145,140
+455.1%
0.02%
+1900.0%
Q3 2019$127,000
-13.6%
26,148
+8.4%
0.00%
-50.0%
Q1 2018$147,000
-33.5%
24,126
-22.5%
0.00%
-50.0%
Q4 2017$221,000
+234.8%
31,127
+197.0%
0.00%
+300.0%
Q2 2017$66,00010,4800.00%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q3 2020
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 5,045,870$5,147,0002.57%
ETF MANAGERS GROUP, LLC 14,101,511$14,243,0000.27%
Ikarian Capital, LLC 948,526$968,0000.07%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 289,627$295,0000.04%
Platform Technology Partners 60,000$61,0000.03%
PINNACLE ASSOCIATES LTD 966,014$985,0000.02%
XTX Topco Ltd 41,599$42,0000.01%
Virtu Financial LLC 160,380$164,0000.01%
Tekla Capital Management LLC 413,481$422,0000.01%
Aries Wealth Management 23,400$24,0000.01%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders